$4.65
0[0.00%]
At close: May 13
$4.65
0[0.00%]
PreMarket: 7:00AM EDT
Summit Therapeutics
(NASDAQ:SMMT)Summit Therapeutics Stock (NASDAQ:SMMT), Earnings Estimates, EPS, and Revenue
Summit Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 1
EPS
$-0.060
Quarterly Revenue
$0K
Annual Revenue
(as of Mar 31)
(as of Mar 31)
–
Analyze the earnings history of Summit Therapeutics using advanced sorting and filters.
No data available to display
ticker | Company Name | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Date | Get Alert |
|---|
FAQ
When is Summit Therapeutics (NASDAQ:SMMT) reporting earnings?
Summit Therapeutics (SMMT) is scheduled to report earnings on August 7, 2024. The last reported earnings were for reported on May 1, 2024 for Q1.
What were the latest earnings per share (EPS) for Summit Therapeutics (NASDAQ:SMMT)?
The Actual EPS was $-0.06, which missed the estimate of $0.00.
What were Summit Therapeutics’s (NASDAQ:SMMT) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.